fda bpc 157 warning not approved human use If BPC-157 worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of Next week, July 23-24, the
Description
The manufacturer pulled Qwo from the market due to a level of visible post-treatment bruising that, they believed, detracted from its commercial viability
BPC-157 has a short plasma half-life (on the order of minutes intravenously ) but its systemic effect exceeds pharmacokinetics, the mechanism acts via signalling cascades and transcription factors
10.1038/nrd3187 145

When it's chronically overloadedfrom running, standing for long periods, or even improper footwearit develops microscopic tears
